Institutional Ownership
Cytomed Therapeutics Limited
CUSIP Y1R80M106SHSGDTCQ1 2026
13D / 13G Filings
12
Schedule 13D/13G on record
Beneficial Filers
6
Distinct reporting persons
Largest Stake
28.9%
Max % of class reported
Institutional Holders
3
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
12 filings · latest Oct 29, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Oct 29, 2025 | Choo Chee Kong | 13D/A | 22.1% | — | SEC |
| 2 | Mar 24, 2025 | Mdr Ltd | 13G/A | 11.3% | 1.31M | SEC |
| 3 | Mar 14, 2025 | Choo Chee Kong | 13D/A | 23.2% | — | SEC |
| 4 | Mar 4, 2025 | 28 Consultants Ltd | 13G | 7.6% | 880.3K | SEC |
| 5 | May 23, 2024 | Choo Chee Kong | 13G/A | 26.6% | 3.07M | SEC |
| 6 | Feb 14, 2024 | Zeng Jieming | 13G | 5.1% | 589.2K | SEC |
| 7 | Feb 14, 2024 | Wang Shu | 13G | 7.7% | 883.9K | SEC |
| 8 | Feb 14, 2024 | Mdr Ltd | 13G | 11.6% | 1.34M | SEC |
| 9 | Feb 14, 2024 | Choo Chee Kong | 13G | 27.4% | 3.16M | SEC |
| 10 | May 19, 2023 | Zeng Jieming | 13D | 5.1% | 589.2K | SEC |
2 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Cytomed Therapeutics Limited.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Xtx Topco Ltd | 10.1K | $10.1K |
| 2 | Ubs Group AG | 6.2K | $6.2K |
| 3 | Osaic Holdings, Inc. | 21 | $21 |